STOCK MARKET BSE NSE

United Kingdom OKs resumption of hydroxychloroquine trial

A large British trial previously found that hydroxychloroquine did not prevent deaths among people hospitalized with COVID-19.

Published: 30th June 2020 04:00 PM  |   Last Updated: 30th June 2020 04:00 PM   |  A+A-

Hydroxychloroquine pills. (Photo | AP)

Hydroxychloroquine pills. (Photo | AP)

By PTI

LONDON: Britain's medical regulatory agency has approved the resumption of a trial testing whether hydroxychloroquine, the malaria drug favoured by US President Donald Trump, might help prevent health workers from contracting the coronavirus.

The Medicines and Healthcare Products Regulatory Agency had suspended enrollment into the trial after a paper was published in the journal Lancet last month that suggested there was an increased death risk linked to the drug.

The paper was found to be based on fraudulent data and was retracted.

A large British trial previously found that hydroxychloroquine did not prevent deaths among people hospitalized with COVID-19 compared to people who didn't get the drug.

The World Health Organization suspended its own trial into the drug, citing data from Britain and elsewhere, but said it was still unknown whether or not hydroxychloroquine might work to prevent coronavirus infections preventively.

In a statement issued on Tuesday, Britain's Medicines and Healthcare Products Regulatory Agency said it had approved the resumption of an ongoing clinical trial testing the use of the drug in health workers.

Oxford University's tropical research center in Bangkok is leading a trial aiming to include more than 40,000 health workers and other staff at risk to determine if hydroxychloroquine can stop infections of the coronavirus.

Stay up to date on all the latest World news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp